![Griffeth Tully](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Griffeth Tully
Plus aucun poste en cours
Historique de carrière de Griffeth Tully
Anciens postes connus de Griffeth Tully
Sociétés | Poste | Début | Fin |
---|---|---|---|
BOSTON SCIENTIFIC CORPORATION | Directeur Technique/Scientifique/R&D | 01/01/2009 | 01/01/2009 |
Embolic Protection, Inc.
![]() Embolic Protection, Inc. Medical DistributorsDistribution Services Embolic Protection, Inc. develops proprietary filters that capture embolic material that is dislodged during cardiovascular surgery. | Directeur Technique/Scientifique/R&D | 01/01/2002 | 01/01/2002 |
Breathometer, Inc.
![]() Breathometer, Inc. Electronic Equipment/InstrumentsElectronic Technology Breathometer, Inc. designs a breathalyzer to determine the blood alcohol into the body. It provides its products under the categories of fitness and sports accessories, health and biotech accessories, biometrics, health and biotech, lifestyle, sensors, wearables and wireless devices. The company was founded by Charles Michael Yim in September 2012 and is headquartered in Burlingame, CA. | Directeur Technique/Scientifique/R&D | - | - |
SILK ROAD MEDICAL, INC | Directeur Technique/Scientifique/R&D | - | - |
CardioKinetix, Inc.
![]() CardioKinetix, Inc. Medical SpecialtiesHealth Technology CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA. | Directeur Technique/Scientifique/R&D | - | - |
Velomedix, Inc.
![]() Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Directeur Technique/Scientifique/R&D | 17/04/2009 | - |
Formation de Griffeth Tully
New York Medical College | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 6 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
SILK ROAD MEDICAL, INC | Health Technology |
Entreprise privées | 4 |
---|---|
Velomedix, Inc.
![]() Velomedix, Inc. Medical SpecialtiesHealth Technology Velomedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury. A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death and preserves organ function. Therapeutic Hypothermia offers a novel solution for the protection of the body's organs during ischemic insults and later from reperfusion injury. Cooling protects tissue during ischemia by reducing oxygen metabolism, inflammation and maintaining cell membrane integrity. In the case of reperfusion injury hypothermia reduces oxidative stress, micro vascular clogging, free radical production and inflammatory responses which are destructive to cells that have had blood flow restored after a period of ischemia. | Health Technology |
Embolic Protection, Inc.
![]() Embolic Protection, Inc. Medical DistributorsDistribution Services Embolic Protection, Inc. develops proprietary filters that capture embolic material that is dislodged during cardiovascular surgery. | Distribution Services |
CardioKinetix, Inc.
![]() CardioKinetix, Inc. Medical SpecialtiesHealth Technology CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
Breathometer, Inc.
![]() Breathometer, Inc. Electronic Equipment/InstrumentsElectronic Technology Breathometer, Inc. designs a breathalyzer to determine the blood alcohol into the body. It provides its products under the categories of fitness and sports accessories, health and biotech accessories, biometrics, health and biotech, lifestyle, sensors, wearables and wireless devices. The company was founded by Charles Michael Yim in September 2012 and is headquartered in Burlingame, CA. | Electronic Technology |
- Bourse
- Insiders
- Griffeth Tully
- Expérience